MeSH tree: D02.455.426.392.368.242
Black patients with early-stage breast cancer who were treated with docetaxel chemotherapy every 3 weeks had less drug-induced peripheral neuropathy and significantly fewer dose reductions compared to those who received weekly ...
Jun 4, 2024
0
31
A team of researchers has uncovered the identity of off-target cells responsible for abnormal outgrowth and devised a method to eliminate them from iPS cell-derived pancreatic tissues in development for cell therapy against ...
May 13, 2024
0
62
When doctors began using the drug sotorasib in 2021 with high expectations for its innovative approach to attacking lung cancer, retired medical technician Don Crosslin was an early beneficiary. Crosslin started the drug ...
May 9, 2024
0
51
For patients with locally advanced prostate cancer, combined treatment with chemotherapy and hormonal therapy offers extended control of prostate-specific antigen (PSA) levels, compared to hormonal therapy alone, according ...
Apr 17, 2024
0
34
A new research perspective titled "Combining causal and correlative approaches to discover biomarkers of response to paclitaxel" has been published in Oncotarget.
Feb 21, 2024
0
43
A team of researchers from the Badalona Applied Research Group in Oncology (B·ARGO) and the Urologic Tumors Unit of the Institut Català d'Oncologia (ICO) and the Germans Trias i Pujol Research Institute (IGTP) have found ...
Feb 2, 2024
0
49
Researchers have identified a receptor protein known as CHRM1 as a key player in prostate cancer cells' resistance to docetaxel, a commonly-used chemotherapy drug to treat advanced cancer that has spread beyond the prostate.
Jan 22, 2024
0
57
Researchers at Tohoku University have discovered a new approach for treating lymph node metastasis. Anticancer drugs are administered directly into the LNs under ultrasound guidance (lymphatic drug delivery system or LDDS) ...
Jan 12, 2024
0
39
Extracts of a plant used in traditional medicine for centuries have shown anti-proliferative effects against breast cancer in a small early-stage clinical trial.
Jan 11, 2024
0
134
Oncode Investigator Mario van der Stelt and his lab discovered a potential new drug that suppresses chemotherapy-induced neuropathic pain. The results are published in Nature Communications.
Dec 6, 2023
0
41
